Abstract:Combinatorial chemistry can be used to synthesize diversified molecules on a large scale. As with all large-scale experiments, this process requires a major investment in equipment, consumables and time. Therefore, careful design is critical. As the complexity of the libraries to be generated increases, additional considerations become important. What are the issues that should be considered when planning combinatorial chemistry projects? Which features in the design strategy are critical to consider ensuring that all of the potential products will be synthesized? How are the reactants selected to optimize product synthesis and yield? Over the last several years, through an experimental process, we have successfully developed and optimized our synthetic strategy. Our approach incorporates a number of critical components into a tightly controlled process that generates molecules with maximal structural complexity. This complexity emanates from carbon-carbon bond formation, which is extremely stable and it is reminiscent of complex natural product molecules. Our studies have illustrated that transition metal catalysts are powerful reagents that can be used to drive the synthesis of diverse small molecules from less complex starting materials. In this review, we will describe some of our recent efforts to synthesize natural product-like molecules and their derivative structures to successfully create libraries of complex molecules for drug discovery applications. Our diversity-oriented synthesis methods incorporate transition metal catalysts, as a versatile tool for creating carbon-carbon bonds and structural complexity, and the branched reaction pathway, as a method for incorporating diversity into the molecular scaffolds. We will review our combinatorial chemistry program, focusing on the decisions that we made for (1) the scaffold selection; (2) the design of a diversity oriented approach for library synthesis; (3) the incorporation of the branched reaction pathway to generate natural product-like molecules from the same starting material; and (4) the process steps that we selected for chemistry development and library generation.

Exploring Diversity through Dimerization in Natural Products by a Rational Tandem Mass-Based Molecular Network Strategy

Diversity Oriented Synthesis and Branching Reaction Pathway to Generate Natural Product-Like Compounds

Diversity-oriented Synthesis of Lycopodium Alkaloids Inspired by the Hidden Functional Group Pairing Pattern.

Diversity-oriented Synthesis of Glycomimetics

Investigations on Biomimetic Dimerization in Natural Product Synthesis

“Carbon Assimilation” Inspired Design and Divergent Synthesis of Drimane Meroterpenoid Mimics As Novel Fungicidal Leads

A General Strategy for Diversifying Complex Natural Products to Polycyclic Scaffolds with Medium-Sized Rings

Methylene-bridged dimeric natural products involving one-carbon unit in biosynthesis

Limonin as a Starting Point for the Construction of Compounds with High Scaffold Diversity

Diversity-Oriented Synthesis of Natural-Product-like Libraries Containing a 3-Methylbenzofuran Moiety for the Discovery of New Chemical Elicitors.

Expanding the Structural Diversity of Drimentines by Exploring the Promiscuity of Two N-methyltransferases

Facile and Divergent Synthesis and Antifungal Evaluation of Drimane Meroterpenoids by Merging Decarboxylative Borylation and Suzuki Coupling

Target Discovery of Dhilirane-Type Meroterpenoids by Biosynthesis Guidance and Tailoring Enzyme Catalysis

Sanyensin with an Unprecedented Architecture: An Effective Strategy from Discovery to Stereochemical Identification of Flexible Natural Products

Natural product driven diversity via skeletal remodeling of caryophyllene β-lactam

Deciphering Fungal Metabolon Coupling Tandem Inverse-Electron-demand Diels-Alder Reaction and Semipinacol Rearrangement for the Biosynthesis of Spiro Polycyclic Alkaloids

Preparation of Stereo-Divergent Compounds from the Natural Product Drupacine Based on Complexity-to-Diversity Strategy

Strategies To Diversify Natural Products For Drug Discovery

Diversity-Oriented Combinatorial Biosynthesis Of Benzenediol Lactone Scaffolds By Subunit Shuffling Of Fungal Polyketide Synthases

Facile and Divergent Optimization of Chromazonarol Enabled the Identification of Simplified Drimane Meroterpenoids As Novel Pharmaceutical Leads.

Metabolomics-Guided Discovery of New Dimeric Xanthones from Co-Cultures of Mangrove Endophytic Fungi Phomopsis asparagi DHS-48 and Phomopsis sp. DHS-11